ABTAbbott Laboratories

Median target
$121
calls from the last 12 months
Implied return
+18.4%
median target vs. price
Coverage
22 analysts · 22 calls
updated in the last 12 months
Consensus
20/2/0+20 net
Buy / Hold / Sell

Which analysts are behind ABT's consensus?

See every current rating, price target and the analysts' track records for Abbott Laboratories — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 22 analysts with calls on ABT updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

ABT elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: #37 in Losing attention (0.7× vs usual)

DateSourceWhoActionDetailAmount
2026-09-02InsidersMccoy John A. Jr.VICE PRESIDENT AND CONTRInsider sale27 sh @ $109.54$3K
2026-08-25InsidersFord Robert BCHAIRMAN AND CEOInsider sale218.5K sh @ $115.57$25.3M
2026-08-25InsidersFord Robert BCHAIRMAN AND CEOInsider sale180.3K sh @ $116.19$20.9M
2026-08-25InsidersRobert B. FordProposed sale398.8K units · 0.02% of shares outstanding$46.2M
2026-08-11InsidersMorrone Louis H.EXECUTIVE VICE PRESIDENTInsider sale5.8K sh @ $109.83$643K
2026-01-30ExecutiveMody, ArjunDeputy CommissionerSaleAbbott Laboratories (ABT)$1,001 - $15,000
2025-12-17ExecutiveTrump, Donald JPresidentPurchaseABBOTT LABORATORIES$15,001 - $50,000
2025-12-12ExecutiveTrump, Donald JPresidentPurchaseABBOTT LABORATORIES$50,001 - $100,000
2025-12-08CongressJulia LetlowLA-LA05Salesince trade -14.4%, vs market +26.4%$1K–$15K
2025-10-29ExecutiveTrump, Donald JPresidentSaleABBOTT LABORATORIES$50,001 - $100,000

More: congressional trades on ABT · insider activity · executive branch · trending